Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Novel Methodology to Measure Protein Accumulation
Authors not listed
Mayo Clinic · 2011
Abstract
Accumulation of damaged proteins is thought to underlie many degenerative conditions, including aging, diabetes, Alzheimer's disease, cataracts, and others. Over time, proteins can be irreversibly damaged by a variety of factors, such as reactive oxygen species, and without timely degradation they can accumulate and aggregate. We believe this can contribute to the development of chronic degenerative disorders.
The purpose of this study is to develop a novel methodology for measuring protein accumulation and test it in two groups of people: young (18-30 years) and old (≥65 years). This methodology will require that people drink a solution of essential amino acids that includes isotopically labeled L\[ring-13C6\]phenylalanine. We will then collect blood and muscle samples, to isolate plasma and skeletal muscle proteins. Participants will return to the study center four more times on a weekly interval.
We hypothesize that older proteins, which persisted in circulation and accumulated over time, will have a higher degree of post-translational oxidative damage than newly synthesized proteins.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-29 MST
Cite this
APA
Anonymous. (2011). Novel Methodology to Measure Protein Accumulation. <em>Mayo Clinic</em>. https://clinicaltrials.gov/study/NCT01505621
Vancouver
Anonymous. Novel Methodology to Measure Protein Accumulation. Mayo Clinic. 2011.
BibTeX
@misc{anon2011NovelM,
title = {Novel Methodology to Measure Protein Accumulation},
author = {Anonymous},
journal = {Mayo Clinic},
year = {2011},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Bispebjerg Hospital 2014
Open access · US-GOV
Counteracting Age-related Loss of Skeletal Muscle Mass
Nature 2000
Citation only
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Baltimore VA Medical Center 2009
Open access · US-GOV
Aging, Inflammation and Exercise in Chronic Stroke
VA Office of Research and Development 2011
Open access · US-GOV
Effects of Aging and Hearing Loss During Rapid Sound Processing
Frontiers in aging 2025
Open access · OA
Biomarker integration and biosensor technologies enabling AI-driven insights into biological aging.
Norwegian School of Sport Sciences 2015
Open access · US-GOV